Utility of urinary circulating tumor DNA for EGFR mutation detection in different stages of non-small cell lung cancer patients

被引：0
|
作者：
Fajiu Li
Jie Huang
Dongyuan Ji
Qinghua Meng
Chuanhai Wang
Shi Chen
Xiaojiang Wang
Zhiyang Zhu
Cheng Jiang
Yi Shi
Shuang Liu
Chenghong Li
机构：
[1] Wuhan No. 6 Hospital,Department of Respiratory Medicine
[2] Affiliated Hospital to Jianghan University,undefined
来源：
Clinical and Translational Oncology | 2017年 / 19卷
关键词：
Non-small-cell lung cancer; Urinary cell free DNA; EGFR mutations; Treatment monitoring;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1283 / 1291
页数：8
相关论文
共 50 条
  • [31] Circulating Tumor DNA Assay and Survival in Patients with Metastatic, Non-Small Cell Lung Cancer
    Ersek, J.
    Hosking, M.
    Symanowski, J.
    Green, E.
    Zhang, Q.
    Kim, E.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S663 - S664
  • [32] Possible application of circulating free tumor DNA in non-small cell lung cancer patients
    Karachaliou, Niki
    Sosa, Aaron E.
    Angel Molina, Miguel
    Centelles Ruiz, Margarita
    Rosell, Rafael
    JOURNAL OF THORACIC DISEASE, 2017, 9 : S1364 - S1372
  • [33] EGFR Mutation Testing in Non-Small Cell Lung Cancer
    Sriram, Krishna B.
    Francis, Santiyagu M. Savarimuthu
    Tan, Maxine E.
    Bowman, Rayleen V.
    Yang, Ian A.
    Fong, Kwun M.
    CURRENT RESPIRATORY MEDICINE REVIEWS, 2010, 6 (04) : 310 - 321
  • [34] Cell-free circulating tumor DNA in plasma of non-small cell lung cancer patients: The role in EGFR T790 M mutation testing
    Sekerus, V.
    Stojanovic, G.
    Bursac, D.
    Tegeltija, D.
    Stolic, M.
    Andrijevic, I.
    CLINICA CHIMICA ACTA, 2019, 493 : S574 - S574
  • [35] Circulating tumor cell analysis in patients with non-small cell lung cancer
    Kato, T.
    Yamada, K.
    Nokihara, H.
    Fukui, T.
    Yamamoto, N.
    Sekine, I.
    Kunitoh, H.
    Ohe, Y.
    Koizumi, F.
    Tamura, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [36] Application of Circulating Tumor DNA as a Biomarker for Non-Small Cell Lung Cancer
    Yang, Jialiang
    Hui, Yan
    Zhang, Yanxiang
    Zhang, Minghui
    Ji, Binbin
    Tian, Geng
    Guo, Yangqiang
    Tang, Min
    Li, Lianxing
    Guo, Bella
    Ma, Tonghui
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [37] Circulating tumor DNA testing in advanced non-small cell lung cancer
    Moding, Everett J.
    Diehn, Maximilian
    Wakelee, Heather A.
    LUNG CANCER, 2018, 119 : 42 - 47
  • [38] Circulating Tumor DNA as a Biomarker in Oligometastatic Non-small Cell Lung Cancer
    Lebow, E. S.
    Murciano-Goroff, Y.
    Razavi, P.
    Reis-Filho, J. S.
    Flynn, J.
    Zhang, Z.
    Tu, H. Y.
    Bertucci, C.
    Lim, L. P.
    Li, M.
    Drilon, A.
    Riely, G.
    Rudin, C. M.
    Jones, D.
    Yang, T. J.
    Rimner, A.
    Arcila, M. E.
    Isbell, J.
    Li, B. T.
    Gomez, D. R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : S174 - S174
  • [39] Treatment Cessation for Improved Detection of EGFR-Mutated Circulating Tumor DNA in Advanced Non-Small Cell Lung Cancer (aNSCLC)
    Tabchi, S.
    Forte, S.
    Alameddine, R.
    Khazzaka, A.
    Florescu, M.
    Kassouf, E.
    Weng, X.
    Tehfe, M.
    Blais, N.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S589 - S590
  • [40] The tumor immune microenvironment at different stages of non-small cell lung cancer
    Hansen, Mackenzie
    Zhou, Qin
    DeRose, Yoko S.
    Kovacsovics, Magdalena
    Brintz, Benjamin
    Witt, Benjamin L.
    O'Neill, Kim L.
    Hu-Lieskovan, Siwen
    CANCER RESEARCH, 2024, 84 (06)
12345